Press Releases and News

September 20 2017

Landos featured in BioWorld

BioWorld Online is the news service of record for the biotechnology industry, and they recently prominently featured Landos’ $10M series A raise. To read the full article, please click here:[...]

July 15 2017

Landos Founder Named 2017 Innovator of the Year

BLACKSBURG, VA. July 15, 2017 —The Roanoke-Blacksburg Technology Council (RBTC) recognized a talented group of companies and individuals at its annual TechNite awards banquet, which was held[...]

June 15 2017

TEDx: Accelerated Path to Cures

BLACKSBURG, VA, June 15, 2017 – Last Friday more than 600 people heard a message of hope and inspiration from Dr. Josep Bassaganya-Riera, founder of Landos Biopharma, Inc. (LANDOS) who[...]

May 15 2017

Landos Recruits New Scientific Director

BLACKSBURG, VA. May 15, 2017 —Landos Biopharma, Inc. (LANDOS) announced today that Dr. Andrew Leber has joined the company to lead efforts aimed at broadening Landos’ therapeutic pipeline[...]

February 15 2017

Landos Vision for Personalized Medicine and Health

BLACKSBURG, VA. February 15, 2017 – Studying the human immune system is like trying to work a vast, multidimensional jigsaw puzzle with pieces that are constantly changing shape. Billions of[...]

December 15 2016

New Indications: LANCL2 in Bacterial Infections

BLACKSBURG, VA. December 15, 2016—Lanthionine synthetase C-like 2 (LANCL2) has been validated as a therapeutic target for inflammatory bowel disease (IBD). New research shows that LANCL2[...]

November 15 2016

LANCL2: A Novel Therapeutic Target for Influenza

BLACKSBURG, VA. November 15, 2016—The Landos Biopharma, Inc. (LANDOS) team has recently explored the potential of activating lanthionine synthetase C-like 2 (LANCL2) to treat infectious[...]